FERTILITY CAPSULE II (FSH, LH, PROLACTIN, E2 & TSH)

Fertility Capsule II is a combined hormone blood-test panel that measures Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), prolactin, estradiol (E2) and Thyroid-Stimulating Hormone (TSH). These hormones provide information about ovarian activity, follicle development, ovulation, pituitary function, estrogen production and thyroid regulation.

Female reproductive health depends on coordinated communication between the hypothalamus, pituitary gland, ovaries and thyroid gland. A hormonal imbalance involving any part of this system may affect menstrual regularity or ovulation. This profile evaluates several important hormones together, helping doctors investigate possible hormonal factors associated with difficulty conceiving.

FSH and LH are produced by the pituitary gland and regulate ovarian function. Estradiol is an estrogen produced mainly by growing ovarian follicles. Prolactin is another pituitary hormone that may disrupt reproductive function when persistently elevated. TSH regulates thyroid-hormone production, and thyroid dysfunction can affect menstrual cycles and fertility.

Benefits of the Test

• Evaluates five hormones involved in menstrual and reproductive health.
• Supports assessment of ovarian-follicle development through FSH.
• Provides information about ovulation-related hormonal activity through LH.
• Measures estradiol to assess estrogen production and ovarian activity.
• Helps identify elevated prolactin that may interfere with ovulation.
• Checks TSH for possible thyroid dysfunction affecting reproductive health.
• Supports evaluation of irregular periods, absent periods and difficulty conceiving.
• Provides baseline hormone values before selected fertility treatments.

Why Doctors Recommend This Test

A doctor may recommend Fertility Capsule II when a woman has difficulty becoming pregnant, irregular menstrual cycles, absent periods or suspected ovulation problems. It may also be requested before fertility treatment or when the doctor needs to evaluate reproductive, pituitary and thyroid hormones together.

FSH stimulates ovarian follicles during the first part of the menstrual cycle. Its concentration changes according to the cycle phase and ovarian response. An elevated early-cycle FSH value may be associated with reduced ovarian response, while a low value may occur with certain hypothalamic or pituitary conditions. FSH should be interpreted with estradiol and other clinical information.

LH works with FSH to regulate ovarian function. A natural LH surge helps trigger ovulation around the middle of the menstrual cycle. Abnormal LH patterns may occur with polycystic ovary syndrome, reduced ovarian function or conditions affecting pituitary and hypothalamic signalling. A single LH result cannot independently confirm whether ovulation occurred.

Estradiol is produced mainly by developing ovarian follicles. Its concentration rises as a follicle matures and changes considerably throughout the menstrual cycle. Measuring E2 with FSH can improve interpretation because an elevated early-cycle estradiol concentration may suppress FSH and make the FSH value appear lower than expected.

Persistently elevated prolactin may suppress reproductive-hormone signalling, contributing to irregular periods, absent periods, reduced ovulation or infertility. Possible causes include pregnancy, breastfeeding, hypothyroidism, certain medicines, kidney disease and pituitary conditions.

Thyroid hormones influence metabolism and reproductive function. Both underactive and overactive thyroid disorders may affect menstrual cycles and ovulation. An abnormal TSH result may lead the doctor to request free T4, thyroid antibodies or other thyroid investigations.

Preparation Before Test

Fasting is generally not required unless the doctor or laboratory provides different instructions. The menstrual-cycle day is important because FSH, LH and estradiol change throughout the cycle. For baseline fertility assessment, these hormones are frequently tested during the early follicular phase, often around cycle day 2 or 3. Follow the exact collection timing recommended by the treating doctor.

Prolactin levels vary during the day and can increase temporarily due to sleep, emotional stress, strenuous exercise, sexual activity or breast stimulation. A morning sample may be advised after the patient has been awake and rested for a specified period.

Provide the date of the last menstrual period, average cycle length and information about irregular bleeding, pregnancy, breastfeeding or fertility treatment. Inform the doctor about hormonal contraceptives, fertility medicines, thyroid medicines, antipsychotic medicines, antidepressants, steroids, biotin and all other medicines or supplements.

Biotin supplements may interfere with certain immunoassay methods. Follow the doctor's or laboratory's instructions regarding supplement use. Never stop prescribed medicine without medical advice.

A healthcare professional will collect a blood sample from a vein, usually in the arm. The procedure generally takes only a few minutes and does not require a recovery period.

Normal Reporting Time

The complete Fertility Capsule II report is commonly available within 24 hours after the laboratory receives a suitable blood sample. Individual components may be processed or verified at different times. Reporting time can vary according to collection time, laboratory workflow, quality-control checks and result verification.

Who Should Take This Test?

This panel may be appropriate for women experiencing difficulty conceiving, irregular or absent menstrual periods, suspected ovulation problems or symptoms of hormonal imbalance. It may also be requested before fertility treatment to establish baseline reproductive and thyroid hormone values.

Doctors may recommend the profile for women with suspected polycystic ovary syndrome, possible reduced ovarian function, early menopausal symptoms, unexpected breast discharge or signs of thyroid dysfunction such as unexplained weight changes, fatigue, temperature sensitivity or menstrual changes.

Fertility Capsule II is not a complete fertility evaluation. Depending on the person's age, history and symptoms, additional assessment may include AMH, progesterone, pelvic ultrasound, antral follicle count, tubal-patency testing and semen analysis of the male partner.

Detailed Information

FSH is released by the anterior pituitary gland and promotes ovarian-follicle growth. Estradiol produced by developing follicles provides feedback to the pituitary gland and influences FSH production. This relationship is why FSH and estradiol are commonly interpreted together.

LH is also produced by the anterior pituitary. During the middle of the menstrual cycle, a surge in LH helps release an egg from the dominant follicle. After ovulation, LH supports the corpus luteum, which produces hormones needed during the second half of the cycle.

The LH-to-FSH relationship may provide additional information in selected cases, but a particular ratio should not be used alone to diagnose PCOS. Diagnosis requires menstrual history, clinical or biochemical signs and, when appropriate, ultrasound findings.

Estradiol is the primary active estrogen during the reproductive years. It supports follicle maturation and growth of the uterine lining. Because E2 varies considerably across the cycle, a result must always be interpreted according to the collection day.

Prolactin supports breast development and milk production. Outside pregnancy and breastfeeding, a persistently elevated level may interfere with ovulation. A mildly elevated result may be repeated under standardised conditions because stress and other temporary factors can influence it.

TSH is released by the pituitary gland and signals the thyroid to produce thyroid hormones. An abnormal TSH does not by itself identify the complete thyroid disorder. Further testing may be required to determine whether thyroid function is contributing to reproductive symptoms.

Reference intervals vary according to age, menstrual-cycle phase, pregnancy status, medicines and analytical method. Results should be interpreted using the ranges printed on the laboratory report and reviewed by a gynaecologist, fertility specialist or another qualified healthcare professional.